Obestatin(human) TFA

Send Inquiry
Obestatin(human) TFA
Details
Human obestatin (TFA);
Category: GI hormone / gastric-emptying and feeding peptide.
Peptide Purity (HPLC) ≥95%
Counter-ion TFA
Structure C-terminal amidated gut peptide (human Obestatin)
Solubility Water, dilute acetic acid/saline
Storage Powder, −20°C, dry, light-protected
Category
Hormone Peptide
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of obestatin(human) tfa in China, also supports custom service. Welcome to wholesale bulk high quality obestatin(human) tfa from our factory. Contact us for more details.

 

  ↵

Description The C-terminal amidated ghrelin-precursor-derived peptide regulating gastric emptying, feeding and body weight; TFA salt.

 

Product Basic Information Table

 

Standard English Name Abbreviation/Synonym Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Obestatin (human), TFA salt Obestatin (human); ghrelin-associated peptide; H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2; FNAPFDVGIKLSGVQYQQHSQAL-NH2; TFA salt; PEP-OBESH-01 gastric gut-brain peptide, ghrelin/obestatin axis, 23-mer C-terminal amide, energy balance and feeding, gastrointestinal motility regulation, receptor debated A 23-residue linear gut-brain peptide, human obestatin: H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 (FNAPFDVGIKLSGVQYQQHSQAL-NH2), with a C-terminal amide (Leu-NH2; amidation is required for activity) and a free N-terminal primary amine; no N-acetylation, no intramolecular disulfide. Composition: Phe×2, Asn×1, Ala×2, Pro×1, Asp×1, Val×2, Gly×2, Ile×1, Lys×1, Leu×2, Ser×2, Gln×4, Tyr×1, His×1; no Met, Trp, Cys or Arg. The sequence was cross-verified against UniProt (GHRL_HUMAN, Q9UBU3; preproghrelin segment 76–98 FNAPFDVGIKLSGVQYQQHSQAL, Leu-98 amidated) and suppliers Tocris (5560), AdooQ (A23125), Echelon and TargetMol; formula C116H176N32O33, external MW 2546.83–2546.88; in-house recalculation gives mono 2545.31 / avg 2546.87 Da, within 0.05 Da of the external average MW. Discrepancy note: the draft candidate FNAPFDVGIKLSGAQYQQHGRAL-NH2 is in fact the full-length RAT obestatin sequence (Bachem H-6338); human and rat differ at positions 14 (Ala→Val), 20 (Gly→Ser) and 21 (Arg→Gln). This entry follows the human sequence. Do not confuse it with the previous batch mouse/rat obestatin (11-23) fragment LSGAQYQQHGRAL-NH2. C116H176N32O33 2545.31 2546.87 TFA salt (trifluoroacetate); formula/MW are calculated on the free-peptide main chain C116H176N32O33, excluding the TFA counterion. The free human obestatin commonly maps to CAS 1081110-72-6 (some suppliers register the TFA form under the same CAS); this batch is listed as the TFA salt. Actual counterion stoichiometry and salt form are per lot COA. 23

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-OBESH-01 White to off-white powder (a 23-mer with basic Lys/His and several Gln residues, near-neutral and moderately hydrophilic; the TFA form is hygroscopic - reseal immediately after opening, keep in a desiccator and weigh rapidly). Store sealed, desiccated and light-protected at −20°C; aliquot single-use portions to avoid repeated freeze-thaw. As a 23-mer it is aggregation- and adsorption-prone, so reconstitution and freeze-thaw should be gentle. Contains Tyr×1 and His×1: keep light-protected throughout to prevent side-chain photo-oxidation. The chain has no Met and no Cys/disulfide, so inert-gass purging against methionine oxidation and disulfide-cleavage restrictions do not apply; protect the TFA salt from moisture; short-term storage at 2–8°C, dry and dark, is acceptable. Store dry and light-protected at 2–8°C; use within 2–4 weeks; store working aliquots frozen at −20°C, dark; ship sealed against moisture. A moderately hydrophilic peptide; first dissolve in water or a weakly acidic buffer (e.g. 0.1 M acetic acid), using a small amount of DMSO as a co-solvent if needed before aqueous dilution. Prepare a low-concentration stock and reconstitute slowly; avoid vigorous vortexing that causes foaming. After reconstitution: ≤1 week at 2–8°C; aliquot and freeze ≤3 months at −20°C; ≤3 freeze-thaw cycles; keep solutions dark; add 0.02% Tween-20 if needed to prevent wall adsorption; avoid pH>8. There is no Cys, so DTT/TCEP are not prohibited, but avoid contact with strong oxidants. Dry-sealed, stable for at least 2 years at 2–8°C; longer-term storage at −20°C; keep moisture-, light- and oxidation-protected.

 

Functional Description

 

Product Code Front-end Short Summary Detailed Biological Function Research Areas (comma-separated) Targets / Receptors
PEP-OBESH-01 Human obestatin, TFA salt, a 23-mer C-amidated peptide (FNAPFDVGIKLSGVQYQQHSQAL-NH2) cleaved from preproghrelin (GHRL gene); main-chain formula C116H176N32O33, MW 2545.31/2546.87. Originally proposed as a satiety peptide opposing ghrelin, but its dedicated receptor (GPR39 was once suggested) and feeding effects remain debated. Obestatin is a 23-residue C-amidated gut-brain peptide cleaved from the 117-residue preproghrelin precursor (GHRL gene, human chromosome 3p25), derived from the same precursor as ghrelin. The human sequence is Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2; C-terminal Leu amidation is required for activity. Zhang et al. (2005, Science) originally reported obestatin as the endogenous ligand of the orphan receptor GPR39, with actions opposite to ghrelin: suppression of feeding, reduced body weight, and delayed gastric emptying and jejunal motility. Subsequent studies failed to reproduce the feeding-suppression effect, GPR39 was shown not to be obestatin's dedicated receptor, and its physiological receptor and precise actions remain debated. The sequence was verified against UniProt Q9UBU3 and Tocris/AdooQ/Echelon/TargetMol; recalculation gives C116H176N32O33, mono 2545.31 / avg 2546.87 Da, within 0.05 Da of external MW 2546.83–2546.88. Applications include the ghrelin/obestatin axis and energy balance, GI motility/gastric emptying, satiety and feeding behavior, gut-brain peptide signaling, and immunoassay standard development. It must be distinguished from rat obestatin (FNAPFDVGIKLSGAQYQQHGRAL-NH2) and the rodent 11-23 C-terminal fragment. Formula/MW are on the free-peptide main chain; the TFA counterion is excluded; salt form per COA. ghrelin/obestatin axis and energy metabolism, GI motility and gastric emptying research, feeding behavior and satiety mechanisms, gut-brain peptide signaling, peptide standards and immunoassay development Derived from preproghrelin (GHRL); originally proposed to act on the orphan GPCR GPR39, but its dedicated receptor has not been established and receptor assignment remains debated; relevant to feeding, GI motility and energy-balance pathways.

 

 

 

 

Hot Tags: obestatin(human) tfa, China obestatin(human) tfa manufacturers, suppliers, factory, 76461-17-1, Bradykinin 1 3 , CAS 23815 91 0, CAS 25696 21 3, GLP 1 9 36 amide, Somatostatin-25

Send Inquiry